08 July 2019
Before undertaking an initiative as important as opening an office in the USA or Canada, it is essential to evaluate with caution the state of the market and the possibilities of success. For a SME like ZeClinics, any investment of this size is a journey full of risks and dangers.
To pave the way, we have incorporated Edelsys Codorniu into our team.
Edelsys completed her undergraduate studies in Nuclear Chemistry at the University of Havana in 1998. Later that year she worked for an Environmental Research Lab. She defended her Ph.D. in Chemistry in 2005 and in 2006 she started leading the Research Group of Molecular Design and Synthesis. In May 2009 she started a Post Doc position at the University of Calgary (UofC) in Canada, where she worked as a Research Associate until 2015. Driven by an entrepreneurial spirit, she has created her own company in Canada and worked as a Business Developer for Intelligent Pharma and Mind the Byte.
Today, we are very excited to have her in ZeClinics, representing us in Canada and the USA.
Welcome aboard Edelsys!